Beijing Leadman Biochemistry Co Ltd Market Cap ($488.78 Million)
Market Cap & Net Worth: Beijing Leadman Biochemistry Co Ltd (300289)
Beijing Leadman Biochemistry Co Ltd market cap. Beijing Leadman Biochemistry Co Ltd (SHE:300289) has a market capitalization of $488.78 Million (CN¥3.34 Billion) as of November 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #12021 globally and #3414 in its home market, demonstrating a 11.03% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Beijing Leadman Biochemistry Co Ltd's stock price CN¥6.14 by its total outstanding shares 544011487 (544.01 Million). Also see Beijing Leadman Biochemistry Co Ltd cash conversion from operations for how efficiently the company converts equity into cash flow.
Beijing Leadman Biochemistry Co Ltd Market Cap History (2015–2026)
Beijing Leadman Biochemistry Co Ltd market cap history from 2015 to 2026. Data shows change from $1.56 Billion to $488.78 Million (-8.93% CAGR). Check today's stock price for Beijing Leadman Biochemistry Co Ltd for real-time trading data and today's change.
Beijing Leadman Biochemistry Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Beijing Leadman Biochemistry Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore 300289 net assets growth trend to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
1.70x
Beijing Leadman Biochemistry Co Ltd's market cap is 1.70 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $978.46 Million | $533.39 Million | $69.65 Million | 1.83x | 14.05x |
| 2017 | $723.48 Million | $575.98 Million | $73.07 Million | 1.26x | 9.90x |
| 2018 | $520.77 Million | $654.80 Million | $40.47 Million | 0.80x | 12.87x |
| 2019 | $459.92 Million | $515.14 Million | $6.31 Million | 0.89x | 72.90x |
| 2020 | $466.33 Million | $471.51 Million | -$50.98 Million | 0.99x | N/A |
| 2021 | $638.93 Million | $564.06 Million | $22.42 Million | 1.13x | 28.50x |
| 2022 | $457.55 Million | $705.98 Million | -$56.27 Million | 0.65x | N/A |
| 2023 | $488.53 Million | $461.55 Million | $15.34 Million | 1.06x | 31.85x |
| 2024 | $390.07 Million | $370.23 Million | -$75.10 Million | 1.05x | N/A |
| 2025 | $554.85 Million | $326.31 Million | -$22.98 Million | 1.70x | N/A |
Competitor Companies of 300289 by Market Capitalization
Companies near Beijing Leadman Biochemistry Co Ltd in the global market cap rankings as of November 4, 2026. Also see 300289 total asset value for a full breakdown of the balance sheet.
Key companies related to Beijing Leadman Biochemistry Co Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $191.55 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $117.68 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #227 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $191.55 Billion | $110.16 |
| #204 | Stryker Corporation | NYSE:SYK | $117.68 Billion | $306.81 |
| #227 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $99.29 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Beijing Leadman Biochemistry Co Ltd (2015–2026)
Market capitalization of Beijing Leadman Biochemistry Co Ltd from 2015 to today. Between 2015 and today, Beijing Leadman Biochemistry Co Ltd's market cap moved from $1.56 Billion to $ 488.78 Million, with a yearly change of -8.93%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥488.78 Million | -11.91% |
| 2025 | CN¥554.85 Million | +42.24% |
| 2024 | CN¥390.07 Million | -20.16% |
| 2023 | CN¥488.53 Million | +6.77% |
| 2022 | CN¥457.55 Million | -28.39% |
| 2021 | CN¥638.93 Million | +37.01% |
| 2020 | CN¥466.33 Million | +1.39% |
| 2019 | CN¥459.92 Million | -11.68% |
| 2018 | CN¥520.77 Million | -28.02% |
| 2017 | CN¥723.48 Million | -26.06% |
| 2016 | CN¥978.46 Million | -37.17% |
| 2015 | CN¥1.56 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Beijing Leadman Biochemistry Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $488.78 Million USD |
| MoneyControl | $488.78 Million USD |
| MarketWatch | $488.78 Million USD |
| marketcap.company | $488.78 Million USD |
| Reuters | $488.78 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Beijing Leadman Biochemistry Co Ltd
Beijing Leadman Biochemistry Co.,Ltd. researches and develops, manufactures, and sells vitro diagnostic reagents and instruments, and biochemical raw materials in the People's Republic of China. The company offers biochemical raw materials, including enzymes, antigens, coenzymes, antibodies, buffers, enzyme substrates, culture mediums, stain agents, amino acids, and other products for biotechnolo… Read more